CASP3 and acute myeloid leukemia: The expression levels of activated caspase-3 significantly increased in AML cell lines (HL-60, NB4, and U937) and primary AML cells after treatment with high concentrations of matrine (1.5 and 2.0 g/L) for 24 h (Fig. 5A and Fig. 5B).